Elbasvir a grazoprevir
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1595/2020/ÚVN | 19. 11. 2020 | Merck Sharp & Dohme s.r.o. | 22 971 520,00 | 20 883 200,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva ElbasGrazo signed 26112020.pdf | Písemná zpráva zadavatele | 26. 11. 2020 12:17 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Merck Sharp & Dohme s.r.o. | Praha 5 |
Price Actually Paid in Each Year of Performance
| 1595/2020/ÚVN | 2023 | 0,00 | 0,00 |
| 1595/2020/ÚVN | 2022 | 3 509 789,22 | 3 190 717,53 |
| 1595/2020/ÚVN | 2021 | 5 831 232,00 | 5 301 120,00 |
| 1595/2020/ÚVN | 2020 | 1 590 336,00 | 1 445 760,00 |